PGR and inflammatory breast carcinoma: In non-IBC, the survival curves for the group with ER% ≥ 91.5% and PR% ≥ 9%, and for the group with ER% < 91.5% and PR% ≥9%, were overlapped for DDFS and OS (Fig. 2a and c).